Related Experiment Video
Updated: Mar 12, 2026

Author Spotlight: Quantification of Aflatoxins and Phytoalexins in Peanut Seeds to Identify Genetic Resistance Against Aspergillus
Published on: April 19, 2024
Escherichia coli CueO Efficiently Detoxifies Aflatoxin B1 via a Mediator-Enhanced Two-Step Mechanism
Qingmei Chen1, Jieying Huang1, Chuan Song1
1State Key Laboratory of Swine and Poultry Breeding Industry, College of Life Sciences, South China Agricultural University, Guangzhou 510642, Guangdong, P. R. China.
None:
Aflatoxin B1 (AFB1) is a highly toxic mycotoxin that threatens global food and feed safety. While enzymatic detoxification is a promising strategy, robust and efficient enzymes remain scarce. This study identified that the multicopper oxidase CueO from Escherichia coli (E. coli) CG1061 transforms AFB1 into the less toxic aflatoxin Q1, exhibiting optimal activity at pH 8 and 60 °C. The CueO-2,2'-azino-bis (3-ethylbenzothazoline-6-sulfonic acid) (ABTS) mediator system achieved >90% of AFB1 transformation in 10 min and complete transformation in 20 min, significantly outperforming CueO alone (51% in 60 min). Mechanistically, CueO oxidizes ABTS to form the ABTṠ+ radical, which subsequently oxidizes AFB1. Mutants (Met510Leu, Asp439Ala, and Pro444Ala) exhibited enhanced enzymatic activity toward ABTS but showed no improvement in the catalytic efficiency for AFB1 transformation. Molecular docking suggests this is because AFB1 binds to surface-exposed residue Ser243, distal to the active site. These findings highlight E. coli CueO's a promising candidate for managing AFB1 contamination.
More Related Videos
09:44RNAi-mediated Control of Aflatoxins in Peanut: Method to Analyze Mycotoxin Production and Transgene Expression in the Peanut/Aspergillus Pathosystem
Published on: December 21, 2015
10:44Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Related Concept Videos
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Phase II Reactions: Miscellaneous Conjugation Reactions
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
Bioremediation
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase